BSE - Delayed Quote INR

Anuh Pharma Limited (ANUHPHR.BO)

216.50
+1.30
+(0.60%)
At close: June 13 at 3:45:51 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
6,615,149
6,615,149
6,470,043
5,274,860
4,866,462
Cost of Revenue
4,993,691
4,993,691
4,866,611
4,014,824
3,776,808
Gross Profit
1,621,458
1,621,458
1,603,432
1,260,036
1,089,654
Operating Expense
1,099,765
1,099,765
937,776
815,551
717,605
Operating Income
521,693
521,693
665,656
444,485
372,049
Net Non Operating Interest Income Expense
-6,193
-6,193
-3,536
-2,965
-5,351
Pretax Income
610,053
610,053
783,098
474,704
391,220
Tax Provision
136,534
136,534
182,523
112,908
85,607
Net Income Common Stockholders
473,519
473,519
600,575
361,796
305,613
Diluted NI Available to Com Stockholders
473,519
473,519
600,575
361,796
305,613
Basic EPS
9.45
9.45
11.98
7.22
6.10
Diluted EPS
9.45
9.45
11.98
7.22
6.10
Basic Average Shares
50,107.83
50,107.83
50,131.47
50,112
50,112
Diluted Average Shares
50,107.83
50,107.83
50,131.47
50,112
50,112
Rent Expense Supplemental
--
--
3,973
3,780
3,770
Total Expenses
6,093,456
6,093,456
5,804,387
4,830,375
4,494,413
Net Income from Continuing & Discontinued Operation
473,519
473,519
600,575
361,796
305,613
Normalized Income
473,519
473,519
600,575
328,615.80
284,534.42
Interest Income
--
--
11,734
4,498
10,448
Interest Expense
6,193
6,193
3,536
2,184
9,609
Net Interest Income
-6,193
-6,193
-3,536
-2,965
-5,351
EBIT
616,246
616,246
786,634
476,888
400,829
EBITDA
703,640
703,640
872,469
573,890
520,426
Reconciled Cost of Revenue
4,993,691
4,993,691
4,866,611
4,014,824
3,776,808
Reconciled Depreciation
87,394
87,394
85,835
97,002
119,597
Net Income from Continuing Operation Net Minority Interest
473,519
473,519
600,575
361,796
305,613
Total Unusual Items Excluding Goodwill
0
0
0
43,535
26,983
Total Unusual Items
0
0
0
43,535
26,983
Normalized EBITDA
703,640
703,640
872,469
530,355
493,443
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
10,354.80
5,904.42
3/31/2022 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VENUSREM.BO Venus Remedies Limited
457.75
+3.21%
 
NOVARTIND.BO Novartis India Limited
1,007.75
+1.69%
 
IOLCP.BO IOL Chemicals and Pharmaceuticals Limited
88.32
-2.11%
 
SHILPAMED.BO Shilpa Medicare Limited
986.15
+2.17%
 
AMRUTANJAN.NS Amrutanjan Health Care Limited
695.45
-0.73%
 
ORCHPHARMA.NS Orchid Pharma Limited
714.10
-0.91%
 
APLLTD.NS Alembic Pharmaceuticals Limited
999.10
+0.65%
 
AKUMS.NS AKUMS DRUGS AND PHARMA L
572.30
+0.52%
 
GLAND.NS Gland Pharma Limited
1,689.70
+1.22%
 
ABBOTINDIA.NS Abbott India Limited
31,515.00
-0.19%